JPRN-UMIN000002507已完成未知
Effects of aggressive lipid-lowering therapy on atherosclerosis and multi-lipoprotein profiling in patients with coronary artery disease - Statin therapy against multi-lipoprotein profiling and atherosclerosis -Secondary- (SAMURAI Study -Secondary-)
agoya University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2009年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
We demonstrated that treatment with pitavastatin attenuated atherosclerotic plaque. This effect was associated with the level of HDL cholesterol, and was stronger in the absence of diabetes and metabolic syndrome in our ischemic heart disease patients.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have suffered from stroke for the past three months. 2) Patients who have suffered from acute myocardial infarction for the past week. 3) Patients planning CABG in the study periods. 4) Patients planning addition or change of cilostazol in the study periods 5) Patients planning CAS in the study periods 6) Patients with active malignant tumor. 7) Patients with severe renal dysfunction. 8) Patients with severe hepatic dysfunction. 9) Patients with collagen disease. 10) Patients judged as being inappropriate for this study by investigators.
研究者
相似试验
Unknown
不适用
Pitavastatin on Carotid Intima-media ThicknessCarotid Artery DiseasesHyperlipidemiaNCT00711919Kyoto Prefectural University of Medicine300
已完成
4 期
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)Coronary Artery DiseaseHyperlipidemiaNCT01023607Harbin Medical University120
已完成
不适用
Investigation oflipid-improving and pleiotrophic effects of pitavastatiJPRN-UMIN000019020Fukui University School of Medical Science60
Unknown
不适用
Hemodynamic Change of Coronary Atherosclerotic Plaque After Evolocumab TreatmentAtherosclerosisNCT04416425Zibo Central Hospital200
已完成
3 期
Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial IschemiaNCT00000488National Heart, Lung, and Blood Institute (NHLBI)